
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
Leli Zeng, Pranav Gupta, Yanglu Chen, et al.
Chemical Society Reviews (2017) Vol. 46, Iss. 19, pp. 5771-5804
Open Access | Times Cited: 890
Leli Zeng, Pranav Gupta, Yanglu Chen, et al.
Chemical Society Reviews (2017) Vol. 46, Iss. 19, pp. 5771-5804
Open Access | Times Cited: 890
Showing 1-25 of 890 citing articles:
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
Thanh Chung Pham, Nguyễn Văn Nghĩa, Yeonghwan Choi, et al.
Chemical Reviews (2021) Vol. 121, Iss. 21, pp. 13454-13619
Closed Access | Times Cited: 1163
Thanh Chung Pham, Nguyễn Văn Nghĩa, Yeonghwan Choi, et al.
Chemical Reviews (2021) Vol. 121, Iss. 21, pp. 13454-13619
Closed Access | Times Cited: 1163
Stimuli-Responsive Therapeutic Metallodrugs
Xiaohui Wang, Xiaoyong Wang, S. Jin, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1138-1192
Closed Access | Times Cited: 554
Xiaohui Wang, Xiaoyong Wang, S. Jin, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1138-1192
Closed Access | Times Cited: 554
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Reece G. Kenny, Celine J. Marmion
Chemical Reviews (2019) Vol. 119, Iss. 2, pp. 1058-1137
Closed Access | Times Cited: 537
Reece G. Kenny, Celine J. Marmion
Chemical Reviews (2019) Vol. 119, Iss. 2, pp. 1058-1137
Closed Access | Times Cited: 537
Metallodrugs are unique: opportunities and challenges of discovery and development
Elizabeth J. Anthony, Elizabeth M. Bolitho, Hannah E. Bridgewater, et al.
Chemical Science (2020) Vol. 11, Iss. 48, pp. 12888-12917
Open Access | Times Cited: 523
Elizabeth J. Anthony, Elizabeth M. Bolitho, Hannah E. Bridgewater, et al.
Chemical Science (2020) Vol. 11, Iss. 48, pp. 12888-12917
Open Access | Times Cited: 523
Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy
Franz Heinemann, Johannes Karges, Gilles Gasser
Accounts of Chemical Research (2017) Vol. 50, Iss. 11, pp. 2727-2736
Open Access | Times Cited: 521
Franz Heinemann, Johannes Karges, Gilles Gasser
Accounts of Chemical Research (2017) Vol. 50, Iss. 11, pp. 2727-2736
Open Access | Times Cited: 521
Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?
Sreekanth Thota, Daniel A. Rodrigues, Debbie C. Crans, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 14, pp. 5805-5821
Closed Access | Times Cited: 418
Sreekanth Thota, Daniel A. Rodrigues, Debbie C. Crans, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 14, pp. 5805-5821
Closed Access | Times Cited: 418
Metal complexes as a promising source for new antibiotics
Angelo Frei, Johannes Zuegg, Alysha G. Elliott, et al.
Chemical Science (2020) Vol. 11, Iss. 10, pp. 2627-2639
Open Access | Times Cited: 398
Angelo Frei, Johannes Zuegg, Alysha G. Elliott, et al.
Chemical Science (2020) Vol. 11, Iss. 10, pp. 2627-2639
Open Access | Times Cited: 398
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Eszter Boros, Paul J. Dyson, Gilles Gasser
Chem (2019) Vol. 6, Iss. 1, pp. 41-60
Open Access | Times Cited: 346
Eszter Boros, Paul J. Dyson, Gilles Gasser
Chem (2019) Vol. 6, Iss. 1, pp. 41-60
Open Access | Times Cited: 346
Supramolecular cancer nanotheranostics
Jiong Zhou, Lang Rao, Guocan Yu, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 4, pp. 2839-2891
Closed Access | Times Cited: 345
Jiong Zhou, Lang Rao, Guocan Yu, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 4, pp. 2839-2891
Closed Access | Times Cited: 345
Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials
Wei‐Hai Chen, Guo‐Feng Luo, Xian‐Zheng Zhang
Advanced Materials (2018) Vol. 31, Iss. 3
Closed Access | Times Cited: 312
Wei‐Hai Chen, Guo‐Feng Luo, Xian‐Zheng Zhang
Advanced Materials (2018) Vol. 31, Iss. 3
Closed Access | Times Cited: 312
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
Enzo Alessio, Luigi Messori
Molecules (2019) Vol. 24, Iss. 10, pp. 1995-1995
Open Access | Times Cited: 312
Enzo Alessio, Luigi Messori
Molecules (2019) Vol. 24, Iss. 10, pp. 1995-1995
Open Access | Times Cited: 312
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 304
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 304
Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy
Kaiyuan Ni, Guangxu Lan, Samuel S. Veroneau, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 290
Kaiyuan Ni, Guangxu Lan, Samuel S. Veroneau, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 290
Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?
Sherri A. McFarland, Arkady Mandel, Roger Dumoulin-White, et al.
Current Opinion in Chemical Biology (2019) Vol. 56, pp. 23-27
Open Access | Times Cited: 283
Sherri A. McFarland, Arkady Mandel, Roger Dumoulin-White, et al.
Current Opinion in Chemical Biology (2019) Vol. 56, pp. 23-27
Open Access | Times Cited: 283
<p>Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives</p>
Sang Yeul Lee, Chul Young Kim, Tae‐gyu Nam
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 5375-5392
Open Access | Times Cited: 281
Sang Yeul Lee, Chul Young Kim, Tae‐gyu Nam
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 5375-5392
Open Access | Times Cited: 281
Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy
Ana Zamora, Gloria Vigueras, Venancio Rodrı́guez, et al.
Coordination Chemistry Reviews (2018) Vol. 360, pp. 34-76
Closed Access | Times Cited: 277
Ana Zamora, Gloria Vigueras, Venancio Rodrı́guez, et al.
Coordination Chemistry Reviews (2018) Vol. 360, pp. 34-76
Closed Access | Times Cited: 277
Type I photodynamic therapy by organic–inorganic hybrid materials: From strategies to applications
Yuying Wang, Yan‐Cen Liu, Hongwei Sun, et al.
Coordination Chemistry Reviews (2019) Vol. 395, pp. 46-62
Closed Access | Times Cited: 269
Yuying Wang, Yan‐Cen Liu, Hongwei Sun, et al.
Coordination Chemistry Reviews (2019) Vol. 395, pp. 46-62
Closed Access | Times Cited: 269
Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy
Johannes Karges, Shi Kuang, Federica Maschietto, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 223
Johannes Karges, Shi Kuang, Federica Maschietto, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 223
Photoactivatable Protherapeutic Nanomedicine for Cancer
Yan Zhang, Cheng Xu, Xiangliang Yang, et al.
Advanced Materials (2020) Vol. 32, Iss. 34
Closed Access | Times Cited: 213
Yan Zhang, Cheng Xu, Xiangliang Yang, et al.
Advanced Materials (2020) Vol. 32, Iss. 34
Closed Access | Times Cited: 213
Photodynamic Therapy—An Up-to-Date Review
Adelina-Gabriela Niculescu, Alexandru Mihai Grumezescu
Applied Sciences (2021) Vol. 11, Iss. 8, pp. 3626-3626
Open Access | Times Cited: 209
Adelina-Gabriela Niculescu, Alexandru Mihai Grumezescu
Applied Sciences (2021) Vol. 11, Iss. 8, pp. 3626-3626
Open Access | Times Cited: 209
A Multi‐action and Multi‐target RuII–PtIV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers
Johannes Karges, Thirumal Yempala, Mickaël Tharaud, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 18, pp. 7069-7075
Open Access | Times Cited: 199
Johannes Karges, Thirumal Yempala, Mickaël Tharaud, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 18, pp. 7069-7075
Open Access | Times Cited: 199
Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii ) polypyridyl complexes as anticancer drug candidates
Anna Notaro, Gilles Gasser
Chemical Society Reviews (2017) Vol. 46, Iss. 23, pp. 7317-7337
Open Access | Times Cited: 194
Anna Notaro, Gilles Gasser
Chemical Society Reviews (2017) Vol. 46, Iss. 23, pp. 7317-7337
Open Access | Times Cited: 194
Harnessing ruthenium(II) as photodynamic agents: Encouraging advances in cancer therapy
Jiangping Liu, Chen Zhang, Thomas W. Rees, et al.
Coordination Chemistry Reviews (2018) Vol. 363, pp. 17-28
Closed Access | Times Cited: 187
Jiangping Liu, Chen Zhang, Thomas W. Rees, et al.
Coordination Chemistry Reviews (2018) Vol. 363, pp. 17-28
Closed Access | Times Cited: 187
Rationally Designed Long-Wavelength Absorbing Ru(II) Polypyridyl Complexes as Photosensitizers for Photodynamic Therapy
Johannes Karges, Franz Heinemann, Marta Jakubaszek, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 14, pp. 6578-6587
Open Access | Times Cited: 184
Johannes Karges, Franz Heinemann, Marta Jakubaszek, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 14, pp. 6578-6587
Open Access | Times Cited: 184
Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure
Ana Rilak Simović, Romana Masnikosa, I. Bratsos, et al.
Coordination Chemistry Reviews (2019) Vol. 398, pp. 113011-113011
Closed Access | Times Cited: 171
Ana Rilak Simović, Romana Masnikosa, I. Bratsos, et al.
Coordination Chemistry Reviews (2019) Vol. 398, pp. 113011-113011
Closed Access | Times Cited: 171